网络研讨会

Tailoring GLP-1 Biosimilar Delivery Systems for the Growing Obesity Market

Written by Stevanato Group | 十二月 04 2024

Introduction

Explore how Stevanato Group’s expertise can help you meet the design and industrialization challenges specific to GLP-1 biosimilar delivery systems.

Learn more about:

  • The Importance of GLP-1 in Obesity Management
  • Designing GLP-1 Biosimilar Delivery Devices
  • Human Factors in Device Design
  • Industrialization and Scale-Up Challenges

Speakers